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Background
The introduction of combined antiretroviral therapy
(cART) since the year 1996, contributed to a rapid, sig-
nificant drop of frequency of all AIDS-defining opportu-
nistic infections and some selected AIDS-related tumors
(like Kaposi’sarcoma), with a consequent, remarkable
reduction of both morbidity and mortality rates asso-
ciated with these disease complications.
Methods
Our cohort of over 1,700 HIV-infected patients followed
in two connected outpatient centres by the same physi-
cian staff were prospectively followed since the year
2000 (9 years), with special interest focused on the diag-
nosis, treatment and outcome of non-AIDS related
malignancies.
Results
Among hematological malignancies other than non-
Hodgkin’s lymphoma and primary central nervous sys-
tem lymphoma, we observed three cases of acute myelo-
genic leukaemia and 4 episodes of Hodgkin’s lymphoma.
A greater number of solid tumors involved different
organs and sites: laryngeal cancer (8 cases, with 6 epi-
sodes of papillomatous laryngeal cancer), rhinopharyn-
geal squamous carcinoma (4 cases), adenocarcinoma of
the lung (6 cases), gastric adenocarcinoma (3 episodes),
esophageal carcinoma (2 patients), prostate cancer (4
cases), bladder adnocarcinoma (3 episodes) pancreatic
adenocarcinoma (2 cases), and squamos anal carcinoma
(2 episodes). Some of these malignancies have been
reported with extremely rare frequency until now
(usually as single-case anecdotal reports), in particular
before the cART era. The patient’s age ranged from 34
to 67 years, the mortality rate of these episodes was very
elevated (over 80%), and occurred 3-41 months after
diagnosis, despite appropriate surgical and/or cytotoxic
chemotherapy and/or radiotherapy.
Discussion
The significantly increased life expectancy of HIV
infected patients in the cART era was characterized by a
proportionally increase of non-AIDS-defining tumors,
which may depend on the advanced mean patients’ age,
their prolonged exposure to risk factor, the persisting
functional immune system imbalance, and probably
some direct oncogenic property of HIV itself, even
when a “quantitative” recovery of CD4+ lymphocyte
count has been achieved thanks to cART. The differen-
tial diagnosis of non-AIDS-associated tumors may be
delayed by the low clinical suspicion, and their fre-
quency to mimick and/or overlap infectious complica-
tions. Further epidemiological and clinical investigation
is strongly warranted, to increase the awareness of this
emerging phenomenon.
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